HomeLoansTetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue Ocean

Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue Ocean

OTTAWA, ON, Aug. 11, 2022 /CNW/ – Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development, announced today that it has entered into a subscription agreement (the “Subscription Agreement“) with Global Corporate Finance Opportunities 16 (the “Investor“), an investment vehicle advised by Alpha Blue Ocean Inc. (“ABO“), whereby Tetra has agreed to issue to the Investor (i) senior unsecured convertible debentures (“Debentures“) in the aggregate principal amount of up to $6,000,000, and (ii) warrants (“Warrants“) to purchase common shares (“Common Shares“) in the capital of the Company (collectively, the “Offering“).

Created in 2017, ABO is a pioneer in alternative financings, providing innovative financing solutions for companies across the globe. In less than 5 years, ABO, founded by Pierre…

Read more at www.newswire.ca

RELATED ARTICLES
- Advertisment -

Most Popular